Quantification of [ <sup>18</sup> F]florbetaben amyloid‐PET imaging in a mixed memory clinic population: The ABIDE project-Reference-Cited by-同舟云学术

Quantification of [ ¹⁸ F]florbetaben amyloid‐PET imaging in a mixed memory clinic population: The ABIDE project

Published:2022-12-07 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Collij Lyduine E.¹,Salvadó Gemma²³,de Wilde Arno⁴,Altomare Daniele⁵⁶,Shekari Mahnaz²⁷⁸,Gispert Juan Domingo²⁷⁹,Bullich Santiago¹⁰,Stephens Andrew¹⁰,Barkhof Frederik¹¹¹,Scheltens Philip⁴,Bouwman Femke⁴,van der Flier Wiesje M.⁴¹²

Affiliation:

1. Department of Radiology and Nuclear Medicine Amsterdam University Medical Center Amsterdam Neuroscience Amsterdam The Netherlands

2. Barcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain

3. Clinical Memory Research Unit Department of Clinical Sciences Lund University Malmö Sweden

4. Department of Neurology Alzheimer Center Amsterdam Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands

5. Laboratory of Neuroimaging of Aging (LANVIE) University of Geneva Geneva Switzerland

6. Memory Center Geneva University Hospitals Geneva Switzerland

7. IMIM (Hospital del Mar Medical Research Institute) Barcelona Spain

8. Pompeu Fabra University Barcelona Spain

9. Centro de Investigación Biomédica en Red de Bioingeniería Biomateriales y Nanomedicina (CIBER‐BBN) Madrid Spain

10. Life Molecular Imaging GmbH Berlin Germany

11. Centre for Medical Image Computing and Queen Square Institute of Neurology UCL London UK

12. Department of Epidemiology & Data Science Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12886

Reference37 articles.

1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

2. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

3. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort

4. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

5. Diagnostic impact of [18F]flutemetamol PET in early-onset dementia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-30

2. Quantification supports amyloid-PET visual assessment of challenging cases: results from the AMYPAD-DPMS study;2024-05-22

3. Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET;PLOS ONE;2024-05-20

4. Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer’s disease based on the A/T(N) research framework;Clinical Neurology and Neurosurgery;2024-01

5. Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population;Alzheimer's Research & Therapy;2023-11-27